These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19012056)

  • 61. [Invasive pneumococcal diseases in children and surveillance systems in Italy].
    Bagnato B; Marino MG; Franco E
    Ig Sanita Pubbl; 2008; 64(6):811-22. PubMed ID: 19219089
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Authors' reply to Prymula R. Re: "Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines" [Vaccine 27 (2009) 4739-4740].
    Rodgers GL; Arguedas A; Cohen R; Dagan R
    Vaccine; 2009 Sep; 27(40):5429-30. PubMed ID: 19643215
    [No Abstract]   [Full Text] [Related]  

  • 63. Serotype replacement in perspective.
    Dagan R
    Vaccine; 2009 Aug; 27 Suppl 3():C22-4. PubMed ID: 19545935
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo.
    Traore Y; Tameklo TA; Njanpop-Lafourcade BM; Lourd M; Yaro S; Niamba D; Drabo A; Mueller JE; Koeck JL; Gessner BD
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S181-9. PubMed ID: 19191614
    [TBL] [Abstract][Full Text] [Related]  

  • 65. National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases.
    Rendi-Wagner P; Paulke-Korinek M; Kundi M; Burgmann H; Georgopoulos A; Vécsei A; Kollaritsch H
    Vaccine; 2009 Jun; 27(30):3963-8. PubMed ID: 19393711
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Pneumococcal disease and emergence of serotypes in the vaccine era. Transient trends and serotype replacement?].
    Moraga-Llop FA
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):1-4. PubMed ID: 19217995
    [No Abstract]   [Full Text] [Related]  

  • 67. New 23-valent pneumococcal vaccine in relation to pneumococcal serotypes in systemic and non-systemic disease.
    Smart LE; Dougall AJ; Girdwood RW
    J Infect; 1987 May; 14(3):209-15. PubMed ID: 3585032
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine.
    Obando I; Arroyo LA; Sánchez-Tatay D; Tarragó D; Moreno D; Hausdorff WP; Brueggemann AB
    Clin Microbiol Infect; 2007 Mar; 13(3):347-8. PubMed ID: 17391398
    [No Abstract]   [Full Text] [Related]  

  • 69. Serious neurologic sequelae in cases of meningitis arising from infection by conjugate vaccine-related and nonvaccine-related serogroups of Streptococcus pneumoniae.
    Rajasingham CR; Bonsu BK; Chapman JI; Cohen DM; Barson WJ
    Pediatr Infect Dis J; 2008 Sep; 27(9):771-5. PubMed ID: 18679153
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults.
    Hak E; Grobbee DE; Sanders EA; Verheij TJ; Bolkenbaas M; Huijts SM; Gruber WC; Tansey S; McDonough A; Thoma B; Patterson S; van Alphen AJ; Bonten MJ
    Neth J Med; 2008 Oct; 66(9):378-83. PubMed ID: 18990781
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 23-valent pneumococcal vaccine failure in a patient who developed pneumonia: a case report.
    Tafuri S; Martinelli D; Grimaldi A; Lopatriello A; Giorgio V; Prato R
    New Microbiol; 2011 Oct; 34(4):417-20. PubMed ID: 22143817
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Serotype replacement in invasive pneumococcal disease: where do we go from here?
    Hanage WP
    J Infect Dis; 2007 Nov; 196(9):1282-4. PubMed ID: 17922390
    [No Abstract]   [Full Text] [Related]  

  • 74. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features.
    Ortqvist A; Hedlund J; Kalin M
    Semin Respir Crit Care Med; 2005 Dec; 26(6):563-74. PubMed ID: 16388428
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Pneumococcal vaccination in obstructive lung diseases -- what can we expect?].
    Rose M; Lode H; de Roux A; Zielen S
    Dtsch Med Wochenschr; 2005 Mar; 130(9):461-5. PubMed ID: 15731959
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease.
    Cockeran R; Anderson R; Feldman C
    Arch Immunol Ther Exp (Warsz); 2005; 53(3):189-98. PubMed ID: 15995579
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology.
    Dortet L; Ploy MC; Poyart C; Raymond J;
    Diagn Microbiol Infect Dis; 2009 Sep; 65(1):49-57. PubMed ID: 19679235
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007.
    Lagos R; Muñoz A; San Martin O; Maldonado A; Hormazabal JC; Blackwelder WC; Levine MM
    J Infect Dis; 2008 Dec; 198(12):1809-17. PubMed ID: 18959497
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Antimicrobial susceptibility and serotype distribution of streptococcus pneumoniae isolates in children in Tunis].
    Smaoui H; Amri J; Hajji N; Kechrid A
    Arch Pediatr; 2009 Mar; 16(3):220-6. PubMed ID: 19216062
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Replacement pneumococcal disease in perspective.
    Pelton SI
    Clin Infect Dis; 2008 May; 46(9):1353-5. PubMed ID: 18419435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.